[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586742":3},{"organization":4,"armGroups":7,"interventions":49,"overallOfficials":55,"centralContacts":64,"locations":70,"responsibleParty":86,"collaborators":90,"id":94,"slug":95,"hasResults":96,"nctId":97,"briefTitle":98,"officialTitle":99,"acronym":55,"eligibilityCriteria":100,"healthyVolunteers":101,"sex":102,"minAge":103,"maxAge":104,"enrollmentInfo":105,"targetDuration":55,"studyType":108,"phases":109,"briefSummary":111,"conditions":112,"keywords":114,"overallStatus":72,"whyStopped":55,"lastUpdateSubmitDate":115,"lastUpdatePostDateStruct":116,"startDateStruct":119,"completionDateStruct":121,"leadSponsor":123,"locationsCount":124},{"fullName":5,"class":6},"Nutraceuticals Research Institute","OTHER",[8,14,18,22,28,32,35,41,45],{"label":9,"type":10,"description":11,"interventionNames":12},"NR via IM injection","EXPERIMENTAL","100mg NR 2ml bacteriostatic water via intramuscular (IM) injection",[13],"Dietary Supplement: Niagen®",{"label":15,"type":10,"description":16,"interventionNames":17},"NR via subcutaneous injection","100mg NR 2ml bacteriostatic water via subcutaneous (SQ) injection",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"NR via IV push","100mg NAD+ 2ml bacteriostatic water via intravenous push (IVP) injection",[13],{"label":23,"type":24,"description":25,"interventionNames":26},"NAD+ via IM injection","ACTIVE_COMPARATOR","100mg NAD+ in 2ml bacteriostatic water via intramuscular (IM) injection",[27],"Other: NAD+",{"label":29,"type":24,"description":30,"interventionNames":31},"NAD+ via subcutaneous injection","100mg NAD+ in 2ml bacteriostatic water via subcutaneous (SQ) injection",[27],{"label":33,"type":24,"description":20,"interventionNames":34},"NAD+ via IV push",[27],{"label":36,"type":37,"description":38,"interventionNames":39},"placebo via IM injection","PLACEBO_COMPARATOR","2ml bacteriostatic water via intramuscular (IM) injection",[40],"Other: Placebo",{"label":42,"type":37,"description":43,"interventionNames":44},"placebo via subcutaneous injection","2ml bacteriostatic water via subcutaneous (SQ) injection",[40],{"label":46,"type":37,"description":47,"interventionNames":48},"placebo via IV push","2ml bacteriostatic water via intravenous push (IVP) injection",[40],[50,56,60],{"type":51,"name":52,"description":53,"armGroupLabels":54,"otherNames":55},"DIETARY_SUPPLEMENT","Niagen®","nicotinamide riboside",[9,19,15],null,{"type":6,"name":57,"description":58,"armGroupLabels":59,"otherNames":55},"NAD+","Nicotinamide adenine dinucleotide",[23,33,29],{"type":6,"name":61,"description":62,"armGroupLabels":63,"otherNames":55},"Placebo","bacteriostatic water",[36,46,42],[65],{"name":66,"role":67,"phone":68,"phoneExt":55,"email":69},"JESSIE HAWKINS, PhD","CONTACT","2562039010","j.hawkins@nutraceuticalsresearch.com",[71],{"facility":5,"status":72,"city":73,"state":74,"zip":75,"country":76,"countryCode":77,"cosmosGeoPoint":78,"geoPoint":83,"contacts":84},"RECRUITING","Huntsville","Alabama","35801","United States","US",{"type":79,"coordinates":80},"Point",[81,82],-86.58594,34.7304,{"lat":82,"lon":81},[85],{"name":66,"role":67,"phone":68,"phoneExt":55,"email":69},{"type":87,"investigatorFullName":88,"investigatorTitle":89,"investigatorAffiliation":5,"oldNameTitle":55,"oldOrganization":55},"PRINCIPAL_INVESTIGATOR","Jessie Hawkins","PhD",[91],{"name":92,"class":93},"ChromaDex, Inc.","INDUSTRY","100586742","absorption-and-tolerability-of-injectable-administration-of-niagen-as-compared-to-nad-100586742",false,"NCT06919328","Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+","Absorption and Tolerability of Injectable Administration of Niagen®+, Nicotinamide Riboside Chloride, a Specialized Form of Vitamin B3, as Compared to NAD+: a Double Blinded, Randomized, Controlled Clinical Trial","Inclusion Criteria:\n\n* Provision of signed and dated informed consent form\n* Stated willingness and demonstrated ability to comply with all study procedures, as well as availability for the duration of the study\n* Lives within 100 miles of the NRI study site\n* Any gender, aged 40-65, inclusive\n* Good general health as evidenced by medical history\n* BMI 25-34.9 kg\u002Fm2\n* Sedentary behavior (defined as \\\u003C20 minutes per day or 100 minutes per week of moderate to vigorous exercise)\n* Demonstrated fatigue (Fatigue Assessment Scale) defined as a below-average score\n* For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use such a method during study participation and for an additional month after the end of the study\n* Agreement to adhere to Lifestyle Considerations throughout study duration\n\nExclusion Criteria:\n\n* Current diagnosis of any seizure disorder, diabetes or insulin resistance, any kidney or liver disorder, heart disease, anemia, cancer, or Parkinson's disease\n* ANY chronic illness (pre-disease state acceptable)\n* Out of range phosphate levels at baseline\n* BMI less than 25 or greater than or equal to 35\n* Pregnancy, trying to conceive, or breastfeeding\n* Known allergic reactions to any components of the intervention or related compounds, including any form of B3\n* Positive COVID-19 test within 30 days of the study period\n* Recent dramatic weight changes (10% change in body weight in the last 6 months)\n* Existing usage of a NAD+ or NAD precursor supplement in any form (oral, nasal, patch, or injection\u002FIV administration), including a B-complex supplement, within 60 days of the study, not including multivitamins.\n* Introducing a new medication, supplement, investigational drug, or other intervention (including lifestyle changes) within 60 days of the start of the study.",true,"ALL","40 Years","65 Years",{"count":106,"type":107},70,"ESTIMATED","INTERVENTIONAL",[110],"NA","This study evaluates the subjective effects of injection administration of NR on healthy adult populations.",[113],"Healthy Aging",[57],"2025-04-07",{"date":117,"type":118},"2025-04-09","ACTUAL",{"date":120,"type":118},"2024-10-31",{"date":122,"type":107},"2025-06-30",{"name":5,"class":6},1]